140 related articles for article (PubMed ID: 31838086)
1. Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
Vanbervliet-Defrance B; Delaunay T; Daunizeau T; Kepenekian V; Glehen O; Weber K; Estornes Y; Ziverec A; Djemal L; Delphin M; Lantuéjoul S; Passot G; Grégoire M; Micheau O; Blanquart C; Renno T; Fonteneau JF; Lebecque S; Mahtouk K
Cancer Lett; 2020 Mar; 472():29-39. PubMed ID: 31838086
[TBL] [Abstract][Full Text] [Related]
2. ADP sensitizes ZL55 cells to the activity of cisplatin.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.
Klingbeil O; Lesche R; Gelato KA; Haendler B; Lejeune P
Cell Death Dis; 2016 Sep; 7(9):e2365. PubMed ID: 27607580
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: role of inhibitor of apoptosis proteins (IAPs) and caspases.
Cregan IL; Dharmarajan AM; Fox SA
Int J Oncol; 2013 Feb; 42(2):444-52. PubMed ID: 23229133
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Schelch K; Hoda MA; Klikovits T; Münzker J; Ghanim B; Wagner C; Garay T; Laszlo V; Setinek U; Dome B; Filipits M; Pirker C; Heffeter P; Selzer E; Tovari J; Torok S; Kenessey I; Holzmann K; Grasl-Kraupp B; Marian B; Klepetko W; Berger W; Hegedus B; Grusch M
Am J Respir Crit Care Med; 2014 Oct; 190(7):763-72. PubMed ID: 25188816
[TBL] [Abstract][Full Text] [Related]
7. Toll-Iike Receptor-3 Activation Enhances Malignant Traits in Human Breast Cancer Cells Through Hypoxia-inducible Factor-1α.
Scatozza F; D'Amore A; Fontanella RA; DE Cesaris P; Marampon F; Padula F; Ziparo E; Riccioli A; Filippini A
Anticancer Res; 2020 Oct; 40(10):5379-5391. PubMed ID: 32988857
[TBL] [Abstract][Full Text] [Related]
8. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.
Taura M; Fukuda R; Suico MA; Eguma A; Koga T; Shuto T; Sato T; Morino-Koga S; Kai H
Cancer Sci; 2010 Jul; 101(7):1610-7. PubMed ID: 20367642
[TBL] [Abstract][Full Text] [Related]
9. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells.
Chuang JH; Chuang HC; Huang CC; Wu CL; Du YY; Kung ML; Chen CH; Chen SC; Tai MH
J Biomed Sci; 2011 Aug; 18(1):65. PubMed ID: 21861882
[TBL] [Abstract][Full Text] [Related]
10. Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent.
Hurwitz JL; Stasik I; Kerr EM; Holohan C; Redmond KM; McLaughlin KM; Busacca S; Barbone D; Broaddus VC; Gray SG; O'Byrne KJ; Johnston PG; Fennell DA; Longley DB
Eur J Cancer; 2012 May; 48(7):1096-107. PubMed ID: 22154545
[TBL] [Abstract][Full Text] [Related]
11. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
12. Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis.
Alkurdi L; Virard F; Vanbervliet B; Weber K; Toscano F; Bonnin M; Le Stang N; Lantuejoul S; Micheau O; Renno T; Lebecque S; Estornes Y
Cell Death Dis; 2018 Aug; 9(9):874. PubMed ID: 30158588
[TBL] [Abstract][Full Text] [Related]
13. Exploiting poly(I:C) to induce cancer cell apoptosis.
Bianchi F; Pretto S; Tagliabue E; Balsari A; Sfondrini L
Cancer Biol Ther; 2017 Oct; 18(10):747-756. PubMed ID: 28881163
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
15. SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.
Crawford N; Stasik I; Holohan C; Majkut J; McGrath M; Johnston PG; Chessari G; Ward GA; Waugh DJ; Fennell DA; Longley DB
Cell Death Dis; 2013 Jul; 4(7):e733. PubMed ID: 23868066
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
17. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8.
Estornes Y; Toscano F; Virard F; Jacquemin G; Pierrot A; Vanbervliet B; Bonnin M; Lalaoui N; Mercier-Gouy P; Pachéco Y; Salaun B; Renno T; Micheau O; Lebecque S
Cell Death Differ; 2012 Sep; 19(9):1482-94. PubMed ID: 22421964
[TBL] [Abstract][Full Text] [Related]
18. Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.
Friboulet L; Gourzones C; Tsao SW; Morel Y; Paturel C; Témam S; Uzan C; Busson P
BMC Cancer; 2010 Jun; 10():327. PubMed ID: 20576118
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.
Lau WH; Zhu XG; Ho SWT; Chang SC; Ding JL
Oncotarget; 2017 May; 8(20):32884-32904. PubMed ID: 28427199
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.
Lin LL; Huang CC; Wu CL; Wu MT; Hsu WM; Chuang JH
Lab Invest; 2016 Jul; 96(7):719-30. PubMed ID: 27183205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
